Register information Patent

DE file number : 60 2011 069 623.8 (Status: pending/in force, Query started: April 26, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 069 623.8
96EP file numberEAKZ16 17 9150.4
97EP publication numberEPN3103469
54Designation/titleTIABGABE THERAPEUTISCHER MITTEL IN DAS ZNS
51IPC main classICM
(ICMV)
A61K 38/47 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61P 25/00 (2006.01), A61P 25/28 (2006.01), A61K 9/19 (2006.01), A61K 9/00 (2006.01), A61K 38/46 (2006.01)
22DE application dateDATJun 25, 2011
96EP application dateEATJun 25, 2011
43Date of first publicationOTDec 14, 2016
Date of publication of grantPETDec 9, 2020
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, 541-0045 Osaka, JP
72InventorINSHAHROKH, Zahra, Weston, MA Massachusetts 02493, US; CALIAS, Pericles, Melrose, MA Massachusetts 02176, US; MCCAULEY, Thomas, Cambridge, MA Massachusetts 02141, US; POWELL, Jan, Concord, MA Massachusetts 01742, US; PAN, Jing, Boxborough, MA Massachusetts 01719, US; PFEIFER, Richard, North Granby, CT Connecticut 06060, US; CHARNAS, Lawrence, Natick, MA Massachusetts 01760, US; WRIGHT, Teresa Leah, Lexington, MA Massachusetts 02142, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161442115 P
Feb 11, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161476210 P
Apr 15, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
387862 P
Sep 29, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
360786 P
Jul 1, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161495268 P
Jun 9, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
358857 P
Jun 25, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161435710 P
Jan 24, 2011
Due dateFT
FG
Jun 30, 2025
Annual fee for the 15th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003103469A1
Searchable text: EP000003103469A1
Original document: EP000003103469B1
Searchable text: EP000003103469B1
43Date of first publicationEVTDec 14, 2016
Date of the first transfer into DPMAregisterEREGTDec 15, 2016
Date of the (most recent) update in DPMAregisterREGTOct 17, 2024
(Show all update days)(Hide all update days)
  • Oct 17, 2024
    • St.36: changed (technical change)
  • May 28, 2024; Jun 3, 2023; Mar 9, 2023; Mar 1, 2023; Feb 14, 2023; May 26, 2022; Oct 21, 2021; Sep 23, 2021; Jun 1, 2021; Feb 19, 2021; Dec 24, 2020; Nov 20, 2020; Nov 19, 2020; Jul 27, 2017
    • Historical data not available for this/these date(s)
  • Dec 15, 2016
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Dec 14, 2016  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Jan 26, 2017 Jan 26, 2017 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Dec 9, 2020  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Dec 31, 2020 Dec 31, 2020 Details anzeigen
5 Opposition procedure Opposition to patent filed Sep 9, 2021 Oct 28, 2021 Details anzeigen
6 New applicant/owner details New applicant/owner details Feb 13, 2023 Mar 23, 2023 Details anzeigen
7 New applicant/owner details New applicant/owner details Mar 8, 2023  Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTDec 14, 2016
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTJan 26, 2017
Issue numberHN4
YearPJ2017
Publication dateVTJan 26, 2017
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTDec 9, 2020
Date of update of the procedureREGTNov 19, 2020
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTDec 31, 2020
Issue numberHN53
YearPJ2020
Publication dateVTDec 31, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTDec 24, 2020
View procedures Opposition procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTOpposition to patent filed
Date of legal/procedural statusVSTTSep 9, 2021
Issue numberHN43
YearPJ2021
Publication dateVTOct 28, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTOct 21, 2021
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTFeb 13, 2023
Issue numberHN12
YearPJ2023
Publication dateVTMar 23, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Co. Ltd., Osaka, JP
71/73Previous applicant/ownerINHFShire Human Genetic Therapies, Inc., Lexington, Mass., US
Date of update of the procedureREGTMar 1, 2023
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMar 8, 2023
71/73Previous applicant/ownerINHFTakeda Pharmaceutical Co. Ltd., Osaka, JP
Date of update of the procedureREGTMar 9, 2023